Healthcare & Medical

16th World Clinical Biomarkers & Companion Diagnostics Summit 2026

The 16th World Clinical Biomarkers & Companion Diagnostics Summit is the flagship, global forum uniting 850+ senior leaders from biopharma, diagnostics, regulatory, healthcare, testing labs, and multimodal communities. The event focuses on accelerating complex biomarkers, developing novel and multimodal endpoints, and fostering drug-diagnostic innovations fo…

Visit the official site
10Speakers
7Sponsors
1Exhibitors
52Sessions
18Companies · in total

Speakers

Programmed at 16th, in alphabetical order.

Amy H. Kao
Senior Vice President, Global Head, Research Unit, & Neuroscience, Immunology & Billerica Campus Head · EMD Serono the Healthcare business of Merck KGaA
Carol Peña
Associate Vice President, Companion Diagnostic Development · Merck
Emanuele De Rinaldis
Vice President & Global Head, Target, Diseases & Systems Biology · Sanofi
Jeff Jackson
Group Vice President, Translational Medicine · Incyte Corporation
Jim Palma
Chief Executive Officer · TargetCancer Foundation
John W. Longshore
Head, Scientific Affairs, Global Oncology Diagnostics · AstraZeneca
Marsha Crochiere
Vice President, Translational Medicine & Research · Pyxis Oncology
Matthew G.Hanna
Vice Chair, Pathology Informatics · University of Pittsburgh Medical Center
Nancy Krunic, Ph.D
Vice President & Precision Medicine Head, Diagnostic Sciences & Partnerships · Novartis
Rowland Illing
Chief Medical Officer & Director, Healthcare & Life Sciences · Amazon Web Services (AWS)

Sponsors

The companies behind the program. Tiers as disclosed.

Foundation Medicine
Guardant Health
Myriad
Natera
Personalis
Roche
Sophia Genetics

Agenda

Selected from 52 sessions.

  • 12:00 pm

    Thought Leadership Workshop in Partnership with Roche

    From Concept to Commercialization: Navigating Multimodal Strategy & Early IVD Migration Join Roche for an interactive workshop session featuring rapid technology demonstrations, l…

  • 12:00 pm

    Thought Leadership Workshop in Partnership with Roche: From Concept to Commercialization: Navigating Multimodal Strategy & Early IVD Migration

    Join Roche for an interactive workshop session featuring rapid technology demonstrations, live polling, table-based breakouts, candid networking and fireside chats. Part 1: The On…

  • 12:00 pm Thought Leadership Workshop in Partnership with Roche

    Thought Leadership Workshop in Partnership with Roche: From Concept to Commercialization: Navigating Multimodal Strategy & Early IVD Migration

    Join Roche for an interactive workshop session featuring rapid technology demonstrations, live polling, table-based breakouts, candid networking and fireside chats. - Part 1: The …

  • 3:30 pm

    Hosted Reception in Partnership with Natera

    Rethinking Clinical Development with ctDNA-MRD: From Early Signals to Late-Phase Strategy Natera is hosting an interactive working session on how ctDNA-MRD can reshape clinical de…

  • 3:30 pm

    Thought Leadership Engager in Partnership with Natera

    Rethinking Clinical Development with ctDNA-MRD: From Early Signals to Late-Phase Strategy Natera is hosting an interactive working session on how ctDNA-MRD can reshape clinical dev…

  • 3:30 pm

    Thought Leadership Engager in Partnership with Natera: Rethinking Clinical Development with ctDNA-MRD: From Early Signals to Late-Phase Strategy

    Natera is hosting an interactive working session on how ctDNA-MRD can reshape clinical development strategy and approaches, both as a biomarker to identify underserved patients tha…

  • 3:30 pm Thought Leadership Engager in Partnership with Natera

    Thought Leadership Engager in Partnership with Natera: Rethinking Clinical Development with ctDNA-MRD: From Early Signals to Late-Phase Strategy

    Natera is hosting an interactive working session on how ctDNA-MRD can reshape clinical development strategy and approaches, both as a biomarker to identify underserved patients tha…

  • 6:15 pm

    Dinner Conversations in Partnership with Guardant Health

    AI is Everywhere: Where is the Impact in Drug Discovery & Development? Biopharma teams have access to more data than ever before - yet turning genomic, epigenomic, and clinical dat…

  • 6:15 pm

    Dinner Conversations in Partnership with Guardant Health: AI is Everywhere: Where is the Impact in Drug Discovery & Development?

    Biopharma teams have access to more data than ever before - yet turning genomic, epigenomic, and clinical data into actionable insights remains a major challenge. Join Guardant He…

Company intelligence

An audience of 18 companies, parsed from the program.

Eighteen companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
0All threespeak · spons · exh
7Sponsoringsponsor only
1Exhibitingexhibitor only
10Speakingspeaker only
Speakers by seniority

80% of the speakers carry senior titles: C-suite, Founder, VP, or Director-level.

  • C-suite220%
  • VP-level660%
  • Other roles220%

Of 10 speakers · classified by free-text title

Most-represented companies
#CompanyRolesSpeakers
1Foundation MedicineSponsor-
2Guardant HealthSponsor-
3MyriadSponsor-
4NateraSponsor-
5PersonalisSponsor-
6RocheSponsor-
7Sophia GeneticsSponsor-
8TakedaExhibitor-
9AstraZeneca1
10AWS1
11EMD Serono the Healthcare business of Merck KGaA1
12Incyte1
13Merck1
14Novartis1
Sponsors by tier
unspecified7
100% of 7

Related events

Same brand, other regions